Correction Reverses Zilver PTX Reported Late Survival Gains in PAD Correction Reverses Zilver PTX Reported Late Survival Gains in PAD

A correction to previously published 5-year trial outcomes in Circulation could make for more uncertainty about the advantages of paclitaxel-delivering devices in peripheral-artery interventions.Medscape Medical News

Source: Medscape Medical News Headlines - February 21, 2019 Category: Consumer Health News Tags: Cardiology News Source Type: news